CMS will not move forward with opening up preferred networks to allow any willing pharmacy the chance to offer preferred cost-sharing, as the agency says in the final Part D rule released Monday (May 19) it needs to further study preferred cost-sharing practices to reconcile conflicting stakeholder reactions to the agency's original proposal. The agency says it continues to believe that there are benefits in increasing transparency and allowing more pharmacies willing to charge lower drug prices in exchange for...